The Jumonji Domain-Containing Histone Demethylase Homolog 1D/lysine Demethylase 7A (JHDM1D/KDM7A) Is an Epigenetic Activator of RHOJ Transcription in Breast Cancer Cells

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 Jul 12

PMID 34249916

Citations 9

Authors

Ziyu Zhang

Baoyu Chen

Yuwen Zhu

Tianyi Zhang

Xiaoling Zhang

Yibiao Yuan

Yong Xu

Affiliations

Soon will be listed here.

Abstract

The small GTPase RHOJ is a key regulator of breast cancer metastasis by promoting cell migration and invasion. The prometastatic stimulus TGF-β activates RHOJ transcription megakaryocytic leukemia 1 (MKL1). The underlying epigenetic mechanism is not clear. Here, we report that MKL1 deficiency led to disrupted assembly of the RNA polymerase II preinitiation complex on the RHOJ promoter in breast cancer cells. This could be partially explained by histone H3K9/H3K27 methylation status. Further analysis confirmed that the H3K9/H3K27 dual demethylase JHDM1D/KDM7A was essential for TGF-β-induced RHOJ transcription in breast cancer cells. MKL1 interacted with and recruited KDM7A to the RHOJ promoter to cooperatively activate RHOJ transcription. KDM7A knockdown attenuated migration and invasion of breast cancer cells and mitigated the growth and metastasis of breast cancer cells in nude mice. KDM7A expression level, either singularly or in combination with that of RHOJ, could be used to predict prognosis in breast cancer patients. Of interest, KDM7A appeared to be a direct transcriptional target of TGF-β signaling. A SMAD2/SMAD4 complex bound to the KDM7A promoter and mediated TGF-β-induced KDM7A transcription. In conclusion, our data unveil a novel epigenetic mechanism whereby TGF-β regulates the transcription of the prometastatic small GTPase RHOJ. Screening for small-molecule inhibitors of KDM7A may yield effective therapeutic solutions to treat malignant breast cancers.

Citing Articles

Epigenome-wide analysis reveals potential biomarkers for radiation-induced toxicity risk in prostate cancer.

Lopez-Pleguezuelos C, Aguado-Barrera M, Carballo-Castro A, Peleteiro P, Calvo-Crespo P, Taboada-Valladares B Clin Epigenetics. 2025; 17(1):43.

PMID: 40050897 PMC: 11887099. DOI: 10.1186/s13148-025-01846-8.

Nuclear localization of BRCA1-associated protein 1 is important in suppressing hepatocellular carcinoma metastasis via CTCF and NRF1/OGT axis.

Xie X, Tsui Y, Zhang V, Yu T, Husain A, Chiu Y Cell Death Dis. 2025; 16(1):123.

PMID: 39984455 PMC: 11845619. DOI: 10.1038/s41419-025-07451-0.

Current advances and future directions in targeting histone demethylases for cancer therapy.

Shin J, Yoo H, Roe J Mol Cells. 2025; 48(3):100192.

PMID: 39938867 PMC: 11889978. DOI: 10.1016/j.mocell.2025.100192.

RhoJ: an emerging biomarker and target in cancer research and treatment.

Shen J, Su X, Wang S, Wang Z, Zhong C, Huang Y Cancer Gene Ther. 2024; 31(10):1454-1464.

PMID: 38858534 DOI: 10.1038/s41417-024-00792-6.

Epigenetic Repression of Chloride Channel Accessory 2 Transcription in Cardiac Fibroblast: Implication in Cardiac Fibrosis.

Shao T, Xue Y, Fang M Front Cell Dev Biol. 2021; 9:771466.

PMID: 34869368 PMC: 8633401. DOI: 10.3389/fcell.2021.771466.

References

Dawson M, Kouzarides T . Cancer epigenetics: from mechanism to therapy. Cell. 2012; 150(1):12-27. DOI: 10.1016/j.cell.2012.06.013. View

Fischle W, Mootz H, Schwarzer D . Synthetic histone code. Curr Opin Chem Biol. 2015; 28:131-40. DOI: 10.1016/j.cbpa.2015.07.005. View

Evelyn C, Wade S, Wang Q, Wu M, Iniguez-Lluhi J, Merajver S . CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Mol Cancer Ther. 2007; 6(8):2249-60. DOI: 10.1158/1535-7163.MCT-06-0782. View

Liu Q, Borcherding N, Shao P, Cao H, Zhang W, Qi H . Identification of novel TGF-β regulated genes with pro-migratory roles. Biochim Biophys Acta Mol Basis Dis. 2019; 1865(12):165537. DOI: 10.1016/j.bbadis.2019.165537. View

Shieh Y, Tice J . Medications for Primary Prevention of Breast Cancer. JAMA. 2020; 324(3):291-292. PMC: 8216042. DOI: 10.1001/jama.2020.9246. View

Li Z, Li P, Lu Y, Sun D, Zhang X, Xu Y . A non-autonomous role of MKL1 in the activation of hepatic stellate cells. Biochim Biophys Acta Gene Regul Mech. 2019; 1862(6):609-618. DOI: 10.1016/j.bbagrm.2019.03.001. View

Li N, Liu S, Zhang Y, Yu L, Hu Y, Wu T . Transcriptional Activation of Matricellular Protein Spondin2 (SPON2) by BRG1 in Vascular Endothelial Cells Promotes Macrophage Chemotaxis. Front Cell Dev Biol. 2020; 8:794. PMC: 7461951. DOI: 10.3389/fcell.2020.00794. View

Wu T, Wang H, Xin X, Yang J, Hou Y, Fang M . An MRTF-A-Sp1-PDE5 Axis Mediates Angiotensin-II-Induced Cardiomyocyte Hypertrophy. Front Cell Dev Biol. 2020; 8:839. PMC: 7509415. DOI: 10.3389/fcell.2020.00839. View

Mao L, Liu L, Zhang T, Qin H, Wu X, Xu Y . Histone Deacetylase 11 Contributes to Renal Fibrosis by Repressing KLF15 Transcription. Front Cell Dev Biol. 2020; 8:235. PMC: 7180197. DOI: 10.3389/fcell.2020.00235. View

10.

Shao J, Weng X, Zhuo L, Yu L, Li Z, Shen K . Angiotensin II induced CSF1 transcription is mediated by a crosstalk between different epigenetic factors in vascular endothelial cells. Biochim Biophys Acta Gene Regul Mech. 2018; 1862(1):1-11. DOI: 10.1016/j.bbagrm.2018.10.001. View

11.

Chaffer C, Weinberg R . Cancer cell of origin: spotlight on luminal progenitors. Cell Stem Cell. 2010; 7(3):271-2. PMC: 2941878. DOI: 10.1016/j.stem.2010.08.008. View

12.

Xie L . MKL1/2 and ELK4 co-regulate distinct serum response factor (SRF) transcription programs in macrophages. BMC Genomics. 2014; 15:301. PMC: 4023608. DOI: 10.1186/1471-2164-15-301. View

13.

Higashijima Y, Matsui Y, Shimamura T, Nakaki R, Nagai N, Tsutsumi S . Coordinated demethylation of H3K9 and H3K27 is required for rapid inflammatory responses of endothelial cells. EMBO J. 2020; 39(7):e103949. PMC: 7110136. DOI: 10.15252/embj.2019103949. View

14.

Liu M, Dong R, Hua Z, Lv N, Ma Y, Huang G . Therapeutic potential of Liuwei Dihuang pill against KDM7A and Wnt/β-catenin signaling pathway in diabetic nephropathy-related osteoporosis. Biosci Rep. 2020; 40(9). PMC: 7502694. DOI: 10.1042/BSR20201778. View

15.

Liu Z, Luo X, Liu L, Zhao W, Guo S, Guo Y . Histone acetyltransferase p300 promotes MKL1-mediated transactivation of catechol-O-methyltransferase gene. Acta Biochim Biophys Sin (Shanghai). 2013; 45(12):1002-10. DOI: 10.1093/abbs/gmt108. View

16.

Weng X, Yu L, Liang P, Li L, Dai X, Zhou B . A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol. 2015; 82:48-58. DOI: 10.1016/j.yjmcc.2015.02.010. View

17.

Li Z, Lv F, Dai C, Wang Q, Jiang C, Fang M . Activation of Galectin-3 (LGALS3) Transcription by Injurious Stimuli in the Liver Is Commonly Mediated by BRG1. Front Cell Dev Biol. 2019; 7:310. PMC: 6901944. DOI: 10.3389/fcell.2019.00310. View

18.

Yang Y, Chen D, Yuan Z, Fang F, Cheng X, Xia J . Megakaryocytic leukemia 1 (MKL1) ties the epigenetic machinery to hypoxia-induced transactivation of endothelin-1. Nucleic Acids Res. 2013; 41(12):6005-17. PMC: 3695508. DOI: 10.1093/nar/gkt311. View

19.

Yu L, Weng X, Liang P, Dai X, Wu X, Xu H . MRTF-A mediates LPS-induced pro-inflammatory transcription by interacting with the COMPASS complex. J Cell Sci. 2014; 127(Pt 21):4645-57. DOI: 10.1242/jcs.152314. View

20.

Ding S, Chen X, Shen K . Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy. Cancer Commun (Lond). 2020; 40(8):329-344. PMC: 7427308. DOI: 10.1002/cac2.12078. View